High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Clinical trial NCT04221035 · RECRUITING

Trial details

NCT number: NCT04221035
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

High-Risk Neuroblastoma Patient With Insufficient Response Chemoimmunotherapy

Start date: 2019-11-05
Primary completion: 2026-11-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.